ArticleArthritis & rheumatology (Hoboken, N.J.)2022

Heavy Chain Constant Region Usage in Antibodies to Peptidylarginine Deiminase 4 as a Marker of Disease Subsets in Rheumatoid Arthritis.

E Gómez-Bañuelos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.